Table 1. The top-ranked CpG sites associated with coffee consumption in blood with/without smoking adjustment.
PEG1 Caucasian Ctrl only, adjusted for age, gender, cell counts (subset1) | WHI Caucasian-only, adjusted for age, cell counts (subset2) | WHI Hispanic-only, adjusted for age, cell counts (subset3) | WHI African American-only, adjusted for age, cell counts (subset4) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CpG | Gene | Chr. | Position (bp)a | Relation to UCSC CpG island | UCSC RefGene groupb | meta.Z | meta. P-value | biCor | P-value | biCor | P-value | biCor | P-value | biCor | P-value | |
(a) Adjusting for chronological age, gender, and blood cell counts | ||||||||||||||||
1 | cg21566642 | Intergenic, near ALPPL2 | 2 | 233284661 | Island | −6.26 | 3.73E−10 | −0.29 | 3.60E−05 | −0.14 | 1.34E−05 | −0.07 | 1.28E−01 | −0.10 | 1.33E−02 | |
2 | cg20333292 | GPR132 | 14 | 105532012 | TSS1500 | 5.05 | 4.33E−07 | 0.28 | 7.43E−05 | 0.05 | 8.67E−02 | 0.13 | 6.87E−03 | 0.07 | 9.10E−02 | |
3 | cg21163128 | BSCL2 | 11 | 62477362 | Island | TSS1500 | 5.00 | 5.70E−07 | 0.28 | 6.77E−05 | 0.10 | 2.40E−03 | 0.09 | 6.23E−02 | 0.04 | 2.80E−01 |
4 | cg23303782 | GRK5 | 10 | 120967744 | S_Shore | Body | 4.81 | 1.49E−06 | 0.29 | 3.55E−05 | 0.06 | 4.37E−02 | 0.09 | 6.39E−02 | 0.06 | 1.14E−01 |
5 | cg26105150 | FSTL5 | 4 | 163085403 | TSS1500 | 4.78 | 1.77E−06 | 0.27 | 1.35E−04 | 0.05 | 8.98E−02 | 0.16 | 6.78E−04 | 0.02 | 5.45E−01 | |
6 | cg19723563 | PTHLH | 12 | 28123034 | Island | TSS200 | 4.74 | 2.13E−06 | 0.17 | 2.14E−02 | 0.07 | 2.20E−02 | 0.13 | 5.22E−03 | 0.08 | 3.77E−02 |
7 | cg17928869 | Intergenic, between EIF1 and KRT42P | 17 | 39822542 | S_Shore | 4.68 | 2.86E−06 | 0.23 | 1.35E−03 | 0.08 | 1.17E−02 | 0.11 | 2.11E−02 | 0.05 | 1.93E−01 | |
8 | cg12866551 | MALRD1 | 10 | 20019641 | 4.66 | 3.12E−06 | 0.23 | 1.48E−03 | 0.07 | 2.04E−02 | 0.14 | 2.75E−03 | 0.03 | 4.21E−01 | ||
9 | cg15722372 | PSMD8 | 19 | 38865020 | N_Shore | TSS200 | 4.65 | 3.26E−06 | 0.20 | 4.55E−03 | 0.05 | 9.92E−02 | 0.10 | 4.67E−02 | 0.11 | 4.94E−03 |
10 | cg19974428 | TMEM130 | 7 | 98468047 | Island | TSS1500 | 4.65 | 3.34E−06 | 0.22 | 2.29E−03 | 0.07 | 3.67E−02 | 0.11 | 2.64E−02 | 0.07 | 5.55E−02 |
11 | cg15140902 | FLJ22536 | 6 | 21667815 | S_Shore | Body | 4.60 | 4.14E−06 | 0.12 | 1.09E−01 | 0.10 | 1.52E−03 | 0.10 | 4.12E−02 | 0.09 | 1.72E−02 |
(b) Adjusting for chronological age, gender, blood cell counts, and smoking | ||||||||||||||||
1 | cg21163128 | BSCL2 | 11 | 62477362 | Island | TSS1500 | 4.95 | 7.36E−07 | 0.30 | 1.87E−05 | 0.09 | 7.19E−03 | 0.09 | 6.96E−02 | 0.04 | 2.82E−01 |
2 | cg08119527 | Intergenic, near PODXL | 7 | 131340667 | 4.84 | 1.28E−06 | 0.30 | 2.81E−05 | 0.09 | 4.68E−03 | 0.09 | 6.27E−02 | 0.03 | 4.44E−01 | ||
3 | cg26331135 | CNTN4 | 3 | 2144068 | S_Shelf | 5'UTR | 4.71 | 2.46E−06 | 0.31 | 1.31E−05 | 0.04 | 1.92E−01 | 0.13 | 7.96E−03 | 0.04 | 2.91E−01 |
4 | cg20333292 | GPR132 | 14 | 105532012 | TSS1500 | 4.62 | 3.85E−06 | 0.24 | 7.22E−04 | 0.06 | 8.21E−02 | 0.12 | 1.36E−02 | 0.06 | 1.04E−01 | |
5 | cg08311403 | ROBO3 | 11 | 124735215 | Island | TSS200 | 4.57 | 4.98E−06 | 0.16 | 3.04E−02 | 0.07 | 3.16E−02 | 0.06 | 2.48E−01 | 0.14 | 2.67E−04 |
Abbreviations: ALPPL2, alkaline phosphatase, placental-like 2; BSCL2, Berardinelli–Seip congenital lipodystrophy 2 (seipin); CNTN4, Contactin 4; EIF1, eukaryotic translation initiation factor 1; FLJ22536, miscRNA; FSTL5, follistatin-like 5; GPR132, G Protein-Coupled Receptor 132; GRK5, G protein-coupled receptor kinase 5; KRT42P, keratin 42 pseudogene; MALRD1, MAM and LDL receptor class A domain containing 1; PODXL, podocalyxin-like; PSMD8, proteasome (prosome, macropain) 26 S subunit, non-ATPase, 8; PTHLH, parathyroid hormone-like hormone; ROBO3, roundabout guidance receptor 3; TMEM130, transmembrane protein 130; TSS, transcription start site; UTR, untranslated region.
List of CpGs associated with coffee consumption, (in/near) gene, chromosome, and CpG island location, gene region, (Stouffer's test) Z-value and P-value from meta-analysis, a robust correlation coefficient (known as biweight midcorrelation) and P-value for daily coffee consumption (in last 3 months in WHI or 12 months in PEG1) and DNA methylation levels within four population subsets.
Location is based on NCBI genome build 37.
TSS500: within 1500 bps of a TSS, TSS200: within 200 bps of a TSS.